Tvardi Therapeutics, Inc. (TVRD)
NASDAQ·Healthcare·Biotechnology
$1.04
+8.06%
Mkt Cap $16.51M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$8.75
Range $3.00 – $13.00
Implied Upside
+745.4%
Consensus $8.75 vs current $1.04
NASDAQ·Healthcare·Biotechnology
$1.04
+8.06%
Mkt Cap $16.51M
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$8.75
Range $3.00 – $13.00
+745.4%
Consensus $8.75 vs current $1.04